全文获取类型
收费全文 | 53856篇 |
免费 | 4498篇 |
国内免费 | 1240篇 |
专业分类
耳鼻咽喉 | 756篇 |
儿科学 | 626篇 |
妇产科学 | 359篇 |
基础医学 | 3503篇 |
口腔科学 | 818篇 |
临床医学 | 9023篇 |
内科学 | 7148篇 |
皮肤病学 | 563篇 |
神经病学 | 3082篇 |
特种医学 | 924篇 |
外国民族医学 | 7篇 |
外科学 | 4005篇 |
综合类 | 9608篇 |
现状与发展 | 6篇 |
一般理论 | 1篇 |
预防医学 | 6827篇 |
眼科学 | 454篇 |
药学 | 5345篇 |
112篇 | |
中国医学 | 3996篇 |
肿瘤学 | 2431篇 |
出版年
2024年 | 124篇 |
2023年 | 1081篇 |
2022年 | 1608篇 |
2021年 | 2710篇 |
2020年 | 2620篇 |
2019年 | 2133篇 |
2018年 | 2327篇 |
2017年 | 2108篇 |
2016年 | 2388篇 |
2015年 | 2175篇 |
2014年 | 4788篇 |
2013年 | 4578篇 |
2012年 | 4164篇 |
2011年 | 4032篇 |
2010年 | 3052篇 |
2009年 | 2501篇 |
2008年 | 2283篇 |
2007年 | 2260篇 |
2006年 | 1820篇 |
2005年 | 1557篇 |
2004年 | 1294篇 |
2003年 | 1183篇 |
2002年 | 844篇 |
2001年 | 800篇 |
2000年 | 632篇 |
1999年 | 535篇 |
1998年 | 429篇 |
1997年 | 366篇 |
1996年 | 350篇 |
1995年 | 349篇 |
1994年 | 321篇 |
1993年 | 240篇 |
1992年 | 185篇 |
1991年 | 154篇 |
1990年 | 177篇 |
1989年 | 139篇 |
1988年 | 113篇 |
1987年 | 115篇 |
1986年 | 91篇 |
1985年 | 173篇 |
1984年 | 148篇 |
1983年 | 102篇 |
1982年 | 121篇 |
1981年 | 78篇 |
1980年 | 90篇 |
1979年 | 37篇 |
1978年 | 52篇 |
1977年 | 38篇 |
1976年 | 31篇 |
1974年 | 27篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
41.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):149-158.e4
BackgroundCoronary artery bypass grafting (CABG) improves survival in patients with heart failure and severely reduced left ventricular systolic function (LVEF). Limited data exist regarding adverse cardiovascular event rates after CABG in patients with heart failure with midrange ejection fraction (HFmrEF; LVEF > 40% and < 55%).MethodsWe analyzed data on isolated CABG patients from the Veterans Affairs national database (2010-2019). We stratified patients into control (normal LVEF and no heart failure), HFmrEF, and heart failure with reduced LVEF (HFrEF) groups. We compared all-cause mortality and heart failure hospitalization rates between groups with a Cox model and recurrent events analysis, respectively.ResultsIn 6533 veterans, HFmrEF and HFrEF was present in 1715 (26.3%) and 566 (8.6%) respectively; the control group had 4252 (65.1%) patients. HFrEF patients were more likely to have diabetes mellitus (59%), insulin therapy (36%), and previous myocardial infarction (31%). Anemia was more prevalent in patients with HFrEF (49%) as was a lower serum albumin (mean, 3.6 mg/dL). Compared with the control group, a higher risk of death was observed in the HFmrEF (hazard ratio [HR], 1.3 [1.2-1.5)] and HFrEF (HR, 1.5 [1.2-1.7]) groups. HFmrEF patients had the higher risk of myocardial infarction (subdistribution HR, 1.2 [1-1.6]; P = .04). Risk of heart failure hospitalization was higher in patients with HFmrEF (HR, 4.1 [3.5-4.7]) and patients with HFrEF (HR, 7.2 [6.2-8.5]).ConclusionsHeart failure with midrange ejection fraction negatively affects survival after CABG. These patients also experience higher rates myocardial infarction and heart failure hospitalization. 相似文献
42.
Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea?
《Sleep medicine》2021
Background/objectiveObstructive sleep apnea (OSA) is independently associated with dyslipidemia, a surrogate marker of atherosclerosis. Low-density lipoprotein (LDL)-cholesterol is accepted as a major independent risk factor for cardiovascular disease. However, non-high-density lipoprotein (HDL)-cholesterol is a better marker of atherogenic dyslipidemia and recommended as a target of lipid lowering therapy. We aimed to assess the prevalence of atherogenic dyslipidemia, and relationship between OSA severity and serum LDL-cholesterol and non-HDL cholesterol levels in OSA patients.MethodsWe retrospectively evaluated treatment naïve 2361 subjects admitted to the sleep laboratory of a university hospital for polysomnography. All subjects’ lipid profile including total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and non-HDL-cholesterol were measured.ResultsOut of 2361 patients (mean age 49.6 ± 11.9 years; 68.9% male, apnea-hypopnea index 36.6 ± 28.4/h), 185 (7.8%) had no OSA and 2176 (92.2%) had OSA. Atherogenic dyslipidemia prevalence was high (57–66%) in OSA patients, and especially increased in severe OSA compared to other groups (p < 0.05). Though total and LDL-cholesterol did not differ between those with and without OSA, non-HDL-cholesterol (p = 0.020), and triglycerides (p = 0.001) were higher and HDL-cholesterol levels (p = 0.018) were lower in OSA patients than non-OSA. Non-HDL-cholesterol was significantly correlated with OSA severity (p < 0.001) and hypoxia parameters (p < 0.01), whereas LDL-cholesterol showed no correlation.ConclusionsAtherogenic dyslipidemia is highly prevalent and non-HDL-cholesterol levels are significantly increased, predominantly in severe OSA patients. Non-HDL-cholesterol but not LDL-cholesterol, is significantly correlated with OSA severity and hypoxia parameters. Therefore, it could be better to use non-HDL-cholesterol, which is a guideline recommended target of lipid therapy, as a marker of atherosclerotic cardiovascular risk in OSA patients. 相似文献
43.
BackgroundStudies indicate the intrinsic relationship between sarcopenia and diabetes mellitus (DM) pathophysiological mechanisms. Changes in insulin and muscular metabolism are features of diabetic patients and can interact as sarcopenic accelerators. Conversely, sarcopenic patients feature lower glucose tolerance and higher serum insulin levels, predisposing them to DM.ObjectiveTo study the association between sarcopenia and DM in a community-dwelling elderly population of the Amazon region.MethodsCross-sectional study, performed in Belém, Brazil, with 1078 patients aged above 60 years old from the Viver Mais Project (VMP). The definition of sarcopenia was based in the European Working Group on Sarcopenia in Older People (EWGSOP). Calf circumference >31 cm was considered normal, muscle strength was discriminated by BMI and measured with the hand grip test, and gait speed <0.8 m/s configured low performance. DM was diagnosed when reported by the patient or medical form, use of hypoglycemic medications/insulin and in the presence of fasting glucose >126 mg/dl or glycated hemoglobin (HbA1c) >6.5% on two occasions. Other medical and socio-demographic data were extracted from medical forms.ResultsThe frequency of sarcopenia was 9.4%, while DM was present in 36.87% of the patients, and had an increased occurrence in the sarcopenic group. Female sex, advanced age, DM, coronary insufficiency, osteoporosis, body mass index, waist circumference, triglycerides and functionality were associated with sarcopenia. In multivariate analysis, sarcopenia remained strongly associated with DM (OR: 3.208, 95%CI: 1.784–5.769).ConclusionThis study describes strong and independent association between sarcopenia and DM. To further clarify these findings, broader prospective cohorts are necessary. 相似文献
44.
45.
46.
目的 分析2005 - 2014年我国老年人肺癌发病的时间趋势,为我国肺癌的防控工作提供依据。方法 根据2008 - 2017年《中国肿瘤登记年报》中肺癌的相关数据,分析2005 - 2014年我国老年人肺癌的发病情况,并通过年度变化百分比(annual percentage change,APC)分析其时间变化趋势。结果 2005 - 2014年我国老年人肺癌的发病率呈上升趋势(APC = 0.71%,P<0.05),其中农村老年人肺癌的发病率从198.9/105上升至250.7/105,上升趋势更明显(APC = 2.81%,P<0.05),尤以农村老年女性肺癌发病率的上升趋势最为明显(APC = 5.26%,P<0.05)。2005 - 2014年中国老年人肺癌的发病在60~64岁和65~69岁组呈上升趋势(APC分别为2.83%和2.04%,均P<0.05),而在农村地区,老年人所有年龄组的肺癌发病率都呈明显上升趋势(APC分别为3.49%,3.86%,1.66%,2.31%,3.49%及6.37%,均P<0.05)。结论 2005 - 2014年我国老年人肺癌发病上升趋势明显,以农村老年女性最为突出,国家应针对高危人群及早开展筛查等工作,降低我国老年人肺癌的流行水平。 相似文献
47.
目的:探讨美托洛尔(β1受体阻滞剂)用于老年COPD合并冠心病史治疗的临床疗效。方法:选取2018年6月—2019年6月在我院接受治疗的60岁以上(包括60岁)COPD合并冠心病史老年患者,分为对照组与观察组。对照组给予接受布地奈德福莫特罗粉吸入剂治疗,观察组在使用布地奈德福莫特罗粉吸入剂治疗的基础上口服琥珀酸美托洛尔缓释片治疗,观察对比两组治疗效果。结果:观察组临床治疗效果优于对照组,观察组住院时长以及并发症的发生率低于对照组(P<0.05),差异具有统计学意义。结论:老年COPD合并冠心病史接受美托洛尔治疗,可有效缩短住院时长、用药效果明显、有效提升用药安全性,值得临床推广。 相似文献
48.
《Nutrition Clinique et Métabolisme》2016,30(2):158-162
IntroductionFor many years, nutrition of the elderly is of a special attention. The food policies wants to value the regional initiatives that can be slowed down, and new techniques of adapted food are in development. Following a tracking of malnutrition in an establishment for dependent elderly, a program of nutritional improvement was set up. It was decided to transform the dishes of the daily menu into small enriched, mixed, prehensile mouthfuls, with for objective to use the remaining capacities of the patients, to adapt the care to their rhythm, to answer their expectations and their nutritional needs.MethodThe agents of texture of the mouthfuls were adapted. Their enrichment and their presentation were specified, as well as the modalities of distribution, in order to allow an easy access as well by the patients, the nursing and the families. Cooled cupboards were used.ResultsThe residents found again the pleasure to eat by themselves, their self-respect and consequently covered better their needs. A decrease of the malnutrition prevalence was observed. Times of exchange with other establishments and a formation were set up to share this tool. Levers were identified to develop this concept under good conditions.ConclusionThe adapted enriched mouthfuls tool seems to be useful. Its application is inseparable of a voluntary multidisciplinary approach, anchored in the knowledge of the accompanied person and in the analysis of her global situation. This tool is adaptable not only in any structure welcoming dependent, old people or not, but also at home. 相似文献
49.
50.